163 related articles for article (PubMed ID: 38255338)
1. Predictive and Diagnostic Values of Systemic Inflammatory Indices in Bronchopulmonary Dysplasia.
Cao L; Liu X; Sun T; Zhang Y; Bao T; Cheng H; Tian Z
Children (Basel); 2023 Dec; 11(1):. PubMed ID: 38255338
[TBL] [Abstract][Full Text] [Related]
2. Role of Systemic Inflammatory Indices in the Prediction of Moderate to Severe Bronchopulmonary Dysplasia in Preterm Infants.
Cakir U; Tayman C; Tugcu AU; Yildiz D
Arch Bronconeumol; 2023 Apr; 59(4):216-222. PubMed ID: 36681603
[TBL] [Abstract][Full Text] [Related]
3. High Neutrophil-to-Lymphocyte Ratio Is an Early Predictor of Bronchopulmonary Dysplasia.
Sun Y; Chen C; Zhang X; Weng X; Sheng A; Zhu Y; Chen S; Zheng X; Lu C
Front Pediatr; 2019; 7():464. PubMed ID: 31781524
[No Abstract] [Full Text] [Related]
4. [Comparing the prognostic value of 3 diagnostic criteria of bronchopulmonary dysplasia in preterm infants].
Wang X; Guo J; Wu YY; Lu YK; Liu DP; Li MC; Li R; Wang YY; Kang WQ
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):36-42. PubMed ID: 38154975
[No Abstract] [Full Text] [Related]
5. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Effectiveness of Systemic Inflammatory Indices in the Diagnosis of Respiratory Distress Syndrome in Preterm with Gestational Age of ≤32 Weeks.
Cakir U; Tugcu AU; Tayman C; Yildiz D
Am J Perinatol; 2024 May; 41(S 01):e1546-e1552. PubMed ID: 36898408
[TBL] [Abstract][Full Text] [Related]
7. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Role of Systemic Inflammatory Indices in Infants with Moderate-to-Severe Hypoxic Ischemic Encephalopathy.
Ceran B; Alyamaç Dizdar E; Beşer E; Karaçağlar NB; Sarı FN
Am J Perinatol; 2024 Feb; 41(3):248-254. PubMed ID: 34666380
[TBL] [Abstract][Full Text] [Related]
9. [Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].
Huang J; Lin XZ; Zheng Z; Wang L; Ou FF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1326-1333. PubMed ID: 36544414
[TBL] [Abstract][Full Text] [Related]
10. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
[TBL] [Abstract][Full Text] [Related]
11. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
12. Predictive values of clinical data,molecular biomarkers, and echocardiographic measurements in preterm infants with bronchopulmonary dysplasia.
Wang H; Yan D; Wu Z; Geng H; Zhu X; Zhu X
Front Pediatr; 2022; 10():1070858. PubMed ID: 36923947
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
[TBL] [Abstract][Full Text] [Related]
14. The Predictive Role of Maternal Biological Markers and Inflammatory Scores NLR, PLR, MLR, SII, and SIRI for the Risk of Preterm Delivery.
Hrubaru I; Motoc A; Moise ML; Miutescu B; Citu IM; Pingilati RA; Popescu DE; Dumitru C; Gorun F; Olaru F; Erdelean I; Forga M; Nicolae N; Citu C
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498555
[TBL] [Abstract][Full Text] [Related]
15. Relationship between hematological parameters and bronchopulmonary dysplasia in premature infants.
Jiang J; Mao Y; Wu J; Zhou Q
J Int Med Res; 2023 Jul; 51(7):3000605231187802. PubMed ID: 37503731
[TBL] [Abstract][Full Text] [Related]
16. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
17. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
18. Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study.
Wang X; Ma Y; Wang S; Dong W; Lei X
BMC Pulm Med; 2022 Mar; 22(1):109. PubMed ID: 35346143
[TBL] [Abstract][Full Text] [Related]
19. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
20. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
